1h Free Analyst Time
The acute respiratory distress syndrome treatment market is forecasted to grow by USD 1.29 billion during 2024-2029, accelerating at a CAGR of 6.9% during the forecast period. The report on the acute respiratory distress syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing focus on lung-protective ventilation strategies, advances in precision medicine and biomarker research, and increasing utilization of ecmo therapy.
The acute respiratory distress syndrome treatment market is segmented as below:
By Distribution Channel
- Hospitals pharmacies
- Retail pharmacies
- Online pharmacies
By Route Of Administration
- Oral
- Injection
- Inhalation
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the acute respiratory distress syndrome treatment market covers the following areas:
- Acute Respiratory Distress Syndrome Treatment Market sizing
- Acute Respiratory Distress Syndrome Treatment Market forecast
- Acute Respiratory Distress Syndrome Treatment Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Distribution Channel
9 Market Segmentation by Route of Administration
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global acute respiratory distress syndrome treatment market: Air Liquide SA, APEPTICO Forschung and Entwicklung GmbH, Athersys Inc., Boston Scientific Corp., Dragerwerk AG and Co. KGaA, Edesa Biotech Inc., Fisher and Paykel Healthcare Corp. Ltd., GE Healthcare Technologies Inc., Getinge AB, Hamilton Medical AG, Koninklijke Philips NV, LivaNova PLC, Medtronic Plc, Nihon Kohden Corp., ResMed Inc., SCHILLER AG, Sleepnet Corp., Smiths Group Plc, Stryker Corp., and Vyaire Medical Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing interest in immunomodulatory therapies for ards."
According to the report, one of the major drivers for this market is the growing focus on lung-protective ventilation strategies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Air Liquide SA
- APEPTICO Forschung and Entwicklung GmbH
- Athersys Inc.
- Boston Scientific Corp.
- Dragerwerk AG and Co. KGaA
- Edesa Biotech Inc.
- Fisher and Paykel Healthcare Corp. Ltd.
- GE Healthcare Technologies Inc.
- Getinge AB
- Hamilton Medical AG
- Koninklijke Philips NV
- LivaNova PLC
- Medtronic Plc
- Nihon Kohden Corp.
- ResMed Inc.
- SCHILLER AG
- Sleepnet Corp.
- Smiths Group Plc
- Stryker Corp.
- Vyaire Medical Inc.
